Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group Plc on 25th June 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc filed the form in its capacity as an exempt principal trader dealing in a client-serving capacity during the relevant period.
The bank confirmed it serves as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its formal connection to the party named in the offer disclosure.
On 25th June 2026, Investec purchased a total of 11,053,700 ordinary shares in Advanced Medical Solutions Group, with prices ranging from a low of 277p to a high of 278.674p per unit.
The bank also recorded sales of 10,683,264 ordinary shares on the same date, with prices ranging between 275p and 279p per unit.
The volume of shares traded on both sides of the ledger represents a substantial level of market activity in Advanced Medical Solutions Group ordinary shares for a single trading session.
Investec confirmed there were no cash-settled derivative transactions, stock-settled derivative transactions, or options exercised in relation to this disclosure filing.
The bank also stated there are no indemnity arrangements, option agreements, or understandings that may serve as an inducement to deal or refrain from dealing with any party to the offer.
Similarly, Investec confirmed no agreements or understandings exist relating to voting rights under any option or future acquisition and disposal of relevant securities linked to any derivative instrument.
The disclosure was formally dated 26th June 2026, with contact details attributed to Abhishek Gawde, reachable by telephone for any related enquiries.
Regulatory disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a recognised Regulatory Information Service to ensure full market transparency.
